Brian Jensen, MD, associate professor of medicine and pharmacology, and colleagues identified for the first-time mechanisms underlying the cardiotoxicity of kinase inhibitors used to treat cancer.
Jensen and Colleagues Identify Underlying Causes of Cardiotoxicity of New Therapies Used to Treat Cancers.